Ulla-Maija Haltia

4PUBLICATIONS
46CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jan 21, 2026
Ex Vivo Immuno-Oncology Platform Reveals Spatial T-cell Infiltration Patterns Linked to ATR Inhibition Responses in High-Grade Serous Ovarian Cancer.

Ashwini Sakrepatna Nagaraj, Matilda Salko, Aditi Sirsikar

|May 05, 2025
Health-related quality of life in adult-type ovarian granulosa cell tumor survivors.

Ulla-Maija Haltia, Saku Torvinen, Saara Bryk

|Apr 02, 2024
Chemotherapy induces myeloid-driven spatial T-cell exhaustion in ovarian cancer.

Inga-Maria Launonen, Erdogan Pekcan Erkan, Iga Niemiec

|Feb 22, 2023
Functional Homologous Recombination Assay on FFPE Specimens of Advanced High-Grade Serous Ovarian Cancer Predicts Clinical Outcomes.

Sanna Pikkusaari, Manuela Tumiati, Anni Virtanen

Pageof 1

Frequent Collaborators

3 joint publications

Anni Virtanen

3 joint publications

Anniina Färkkilä

3 joint publications

Sampsa Hautaniemi

3 joint publications

Matilda Salko